company
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences
Industry: pharmaceutical
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_warning_letter · warning_letter2026-04-29Sourav K. Mishra, M.D. / All India Institute of Medical Sciences — In Vivo Bioavailability-Bioequivalence Studies – Clinical (2026-04-29)
Frequently asked questions
- How many FDA warning letters has Sourav K. Mishra, M.D. / All India Institute of Medical Sciences received?
- Argus HQ has recorded 1 FDA warning letter for Sourav K. Mishra, M.D. / All India Institute of Medical Sciences.
- What FDA recalls has Sourav K. Mishra, M.D. / All India Institute of Medical Sciences issued?
- Argus HQ has not recorded an FDA recall tied to Sourav K. Mishra, M.D. / All India Institute of Medical Sciences in our current dataset.
- Is Sourav K. Mishra, M.D. / All India Institute of Medical Sciences FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Sourav K. Mishra, M.D. / All India Institute of Medical Sciences. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.